Skip to content

CBD: all studies

Page 19 of 38: studies 181 to 190 of 375, newest first. Back to the CBD overview

Research

Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry.

Expert Review of Neurotherapeutics 2022 Manaswini Pillai, Simon Erridge, Lara Bapir et al. 27 citations

The current paucity of clinical evidence limits the use of cannabis-based medicinal products (CBMPs) in post-traumatic stress disorder (PTSD). This study investigates health-related quality of life (HRQoL) changes and adverse events in patients prescribed CBMPs for PTSD. A case-series of patients from the UK Medical Cannabis Registry was analyzed. HRQoL was assessed at 1-, 3-, and 6-months...

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials

Addiction Biology December 22, 2021 Thomas R. Arkell, Richard C. Kevin, Frederick Vinckenbosch et al. 45 citations

Some evidence suggests that males and females may differ in their responses to acute cannabis effects, including subjective drug effects and behavioural effects, and cannabinoid pharmacokinetics. This is significant given current changes to cannabis-related policies and, in consequence, increased cannabis accessibility. The present study combines data from two randomized controlled trials to...

DOI: 10.1111/adb.13125 (opens in new tab) Cannabidiol Randomized controlled trial Effects of cannabis Cannabis dependence +1

Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment.

Pharmacological Research December 1, 2021 Tibor Stark, Serena di Martino, Filippo Drago et al.

The recent shift in socio-political debates and growing liberalization of Cannabis use across the globe has raised concern regarding its impact on vulnerable populations such as adolescents. Concurrent with declining perception of Cannabis harms, more adolescents are using it daily in several countries and consuming marijuana strains with high content of psychotropic delta...

"ABERRANT" NEURONAL STIMULATION AND "CANNABIS PSYCHOSIS" - HYPOTHESIS TO A BIOLOGICAL PLAUSIBILITY!

Psychiatria Danubina November 17, 2021 Nileswar Das 3 citations

Western democracies continue to 'legalize recreational cannabis use' after its 'medicinal approval', while India continues to debate whether to 'decriminalize' cannabis or not. One of the strongest arguments against cannabis decriminalization is cannabis dependence and the risk of psychosis, at-least in the vulnerable groups. Endocannabinoids are involved in neuronal proliferation and...

DOI: 10.24869/psyd.2021.280 (opens in new tab) Cannabidiol Psychosis Effects of cannabis Schizophrenia object-oriented programming +1

HIV Transgenic Rats Demonstrate Impaired Sensorimotor Gating But Are Insensitive to Cannabinoid (Δ9-Tetrahydrocannabinol)-Induced Deficits.

The International Journal of Neuropsychopharmacology November 12, 2021 Benjamin Z Roberts, Arpi Minassian, Adam L. Halberstadt et al.

HIV-associated neurocognitive disorder (HAND) is commonly observed in persons living with HIV (PWH) and is characterized by cognitive deficits implicating disruptions of fronto-striatal neurocircuitry. Such circuitry is also susceptible to alteration by cannabis and other drugs of abuse. PWH use cannabis at much higher rates than the general population, thus prioritizing the characterization of...

Theta and Alpha Oscillatory Activity During Working Memory Maintenance in Long-Term Cannabis Users: The Importance of the Polydrug Use Context

Frontiers in Human Neuroscience October 18, 2021 Alicja Anna Binkowska, Natalia Jakubowska, Klaudia Krystecka et al. 7 citations

Background: Impairments in various subdomains of memory have been associated with chronic cannabis use, but less is known about their neural underpinnings, especially in the domain of the brain’s oscillatory activity. Aims: To investigate neural oscillatory activity supporting working memory (WM) in regular cannabis users and non-using controls. We focused our analyses on frontal midline theta...

DOI: 10.3389/fnhum.2021.740277 (opens in new tab) Cannabidiol Context archaeology Working memory Electroencephalography +5

Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.

Journal of basic and clinical physiology and pharmacology March 4, 2021 Marika L Forsythe, Andrew J Boileau

Post-traumatic Stress Disorder (PTSD) is a diagnosis of extreme anxiety caused by a traumatic event. Less than 10% of individuals who have experienced severe trauma will develop this disorder. Treatment options include various psychotherapies, but not all patients respond to them. Different pharmacological approaches have been explored as potential adjuvants, including using cannabinoids to...

Optogenetic brain‐stimulation reward: A new procedure to re‐evaluate the rewarding versus aversive effects of cannabinoids in dopamine transporter‐Cre mice

Addiction Biology February 3, 2021 Bree A. Humburg, Chloe J. Jordan, Hai‐Ying Zhang et al. 30 citations

Abstract Despite extensive research, the rewarding effects of cannabinoids are still debated. Here, we used a newly established animal procedure called optogenetic intracranial self‐stimulation (ICSS) (oICSS) to re‐examine the abuse potential of cannabinoids in mice. A specific adeno‐associated viral vector carrying a channelrhodopsin gene was microinjected into the ventral tegmental area (VTA)...

DOI: 10.1111/adb.13005 (opens in new tab) Full text (opens in new tab) Cannabidiol Ventral tegmental area Optogenetics Brain stimulation reward +8

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.

Pharmacological Research February 2021 Martina di Bartolomeo, Tibor Stark, Oriana Maria Maurel et al.

Perinatal exposure to Δ9-tetrahydrocannabinol (THC) affects brain development and might increase the incidence of psychopathology later in life, which seems to be related to a dysregulation of endocannabinoid and/or dopaminergic systems. We here evaluated the transcriptional regulation of the genes encoding for the cannabinoid CB1 receptor (Cnr1) and the dopamine D2 receptor (Drd2) in perinatal...

Quality of Life and a Surveillant Endocannabinoid System.

Frontiers in Neuroscience 2021 Ricardo Augusto De Melo Reis, Alinny Rosendo Isaac, Hércules Rezende Freitas et al.

The endocannabinoid system (ECS) is an important brain modulatory network. ECS regulates brain homeostasis throughout development, from progenitor fate decision to neuro- and gliogenesis, synaptogenesis, brain plasticity and circuit repair, up to learning, memory, fear, protection, and death. It is a major player in the hypothalamic-peripheral system-adipose tissue in the regulation of food...